ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 38 filers reported holding ORCHARD THERAPEUTICS PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,645,000 | -76.4% | 440,801 | -70.4% | 0.03% | -81.6% |
| Q1 2020 | $11,207,000 | -37.7% | 1,488,314 | +13.7% | 0.15% | -8.1% |
| Q4 2019 | $17,993,000 | +81.9% | 1,308,597 | +57.2% | 0.16% | +61.6% |
| Q3 2019 | $9,889,000 | -1.0% | 832,429 | +16.6% | 0.10% | +3.1% |
| Q2 2019 | $9,986,000 | -21.6% | 713,829 | +0.2% | 0.10% | -20.0% |
| Q1 2019 | $12,741,000 | +26.0% | 712,591 | +10.9% | 0.12% | +13.2% |
| Q4 2018 | $10,110,000 | – | 642,741 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 5,307,751 | $3,101,000 | 1.18% |
| TANG CAPITAL MANAGEMENT LLC | 2,000,000 | $1,168,000 | 0.18% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $4,060,000 | 0.08% |
| Artal Group S.A. | 1,803,858 | $1,054,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 616,402 | $360,000 | 0.05% |
| RA Capital Management | 3,040,885 | $1,776,000 | 0.05% |
| Forefront Analytics, LLC | 92,641 | $58,000 | 0.03% |
| Temasek Holdings (Private) Ltd | 4,319,049 | $2,523,188 | 0.01% |
| FEDERATED HERMES, INC. | 8,309,859 | $4,853,000 | 0.01% |
| Cormorant Asset Management, LP | 256,649 | $150,000 | 0.01% |